P595: Early medical therapy and risk of subsequent perianal fistula development among paediatric patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P596: An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD
ECCO '19 Copenhagen
2019
P597: Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis
ECCO '19 Copenhagen
2019
P598: Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study
ECCO '19 Copenhagen
2019
P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)
ECCO '19 Copenhagen
2019
P600: Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland
ECCO '19 Copenhagen
2019
P601: Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn’s disease
ECCO '19 Copenhagen
2019
P602: CD-TREAT a novel dietary therapy of active Crohn’s disease using the exclusive enteral nutrition paradigm
ECCO '19 Copenhagen
2019
P603: Paediatric onset inflammatory bowel disease is not associated with more disability compared with adult onset disease
ECCO '19 Copenhagen
2019
P604: Biologics with or without a combination with 5-ASA in ulcerative colitis: frequency of usage and effect on the course of disease in the Swiss IBD-Cohort study
ECCO '19 Copenhagen
2019
P605: CRP reduction rate following initiation of anti-tumour necrosis factor-α induction therapy predicts secondary loss of response in patients with Crohn's disease
ECCO '19 Copenhagen
2019
P606: Steroid use in inflammatory bowel disease patients on biological therapy in Montenegro
ECCO '19 Copenhagen
2019
P607: Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P608: Crohn’s disease patients with high baseline symptoms achieve clinical remission more rapidly with Budesonide than with Mesalazine
ECCO '19 Copenhagen
2019
P609: Handsewn anastomosis after ileo-colic resection for Crohn’s disease: a lost art?
ECCO '19 Copenhagen
2019
P610: Penetration, short- and long-term efficacy of anti-TNF-α therapy for ulcerative colitis between 2010–2016 in Hungary
ECCO '19 Copenhagen
2019
P611: A real-world assessment of golimumab effect on quality of life, healthcare resource utilisation and work productivity in patients with ulcerative colitis in Greece: interim results from the GO-LIFE study
ECCO '19 Copenhagen
2019
P612: Long-term outcomes of treatment intervention according to the severity of small bowel capsule endoscopy findings in patients with Crohn’s disease: A Japanese single-centre cohort study
ECCO '19 Copenhagen
2019